The Photodermatology Society
promotes a greater understanding
of light in health and disease.

Our core goal of promoting a greater understanding of the effects of light in health and disease has not changed.

 

The 31st Annual Meeting of the Photodermatology Society
(formerly the Photomedicine Society)

March 24, 2022
Marina Ballroom 1
Westin Boston Seaport
425 Summer Street
Boston, Massachusetts, USA
(Zoom link TBA)

The Photodermatology is planning a hybrid annual meeting which will be held March 24, 2022. This page will be updated as information becomes available.



s
PROGRAM
8:25 – 8:30 Opening Remarks
Steven Q. Wang, MD, Basking Ridge, New Jersey
New and Now: Innovations and Cutting Edge Research
8:30 – 8:55 Harvey Lui, MD, Vancouver, British Columbia, Canada
What Does Spectroscopy Tell Us About the Skin?
8:55 – 9:20 Merete Haedersdal, MD, PhD, Copenhagan, Denmark
Laser-assisted Drug Delivery in Dermatology/tr>
9:20 – 9:35 Giovanni Leone, MD, Rome, Italy
Future Collaboration Perspectives Between Europe (ESPD) and US (Photodermatology Society)
9:35 – 10:00 Break/Poster Viewing
Abstract Presentations
10:00 – 10:15 TBA
10:15 – 10:30 TBA
Phototherapy
10:30 – 10:55 Henry Lim, MD, Detroit, Michigan
Visible Light Photoprotection
10:55 – 11:15 Amy McMichael, MD, Winston-Salem, North Carolina
Photoprotection for People of Color
11:15 – 11:30 Q&A
11:30 – 1:00 Break
Keynote Speakers
1:00– 1:40 Iain Davies, PhD, Washington, District of Columbia
Environmental Safety Assessment of UV Filters
1:40 – 2:00 Q&A
2:00 – 2:15 Break
Photoprotection in Skin of Color
2:15 – 2:20 Introduction
Steven Q. Wang, MD, Basking Ridge, New Jersey
2:20 – 2:40 Da Zhang, PhD, Washington, District of Columbia
Utility of Quantitative Pharmacology and Pharmacometrics in Investigating Active Sunscreen Ingredients Absorption
2:40 – 3:00 Alexandra Kowcz, MBA, Washington, District of Columbia
Sunscreen Consortium - 2022 Update
3:00 – 3:20 Carl D-Ruiz, MPH, Parsippany, New Jersey
Maximum Usage Trial (MUsT) Evaluation of Bemotrizinol – A New Sunscreen Active Ingredient Being Considered for Inclusion on FDA’s OTC Sunscreen Monograph
3:20 – 3:40 Uli Osterwalder, MS, Basel, Switzerland
SPF - The New Way of Looking
3:40 – 4:15 Q&A